TCW Group Inc. Has $68.80 Million Stake in Metlife Inc (MET)

TCW Group Inc. lifted its stake in shares of Metlife Inc (NYSE:MET) by 12.7% during the third quarter, HoldingsChannel reports. The firm owned 1,472,658 shares of the financial services provider’s stock after acquiring an additional 166,277 shares during the quarter. TCW Group Inc.’s holdings in Metlife were worth $68,802,000 as of its most recent SEC filing.

Several other institutional investors also recently made changes to their positions in the company. Cowen Prime Services LLC raised its stake in shares of Metlife by 19.8% during the 2nd quarter. Cowen Prime Services LLC now owns 6,650 shares of the financial services provider’s stock worth $290,000 after purchasing an additional 1,100 shares in the last quarter. Rockefeller Capital Management L.P. increased its holdings in shares of Metlife by 2.1% during the 2nd quarter. Rockefeller Capital Management L.P. now owns 54,305 shares of the financial services provider’s stock worth $2,368,000 after acquiring an additional 1,124 shares during the last quarter. Trust Co. of Vermont increased its holdings in shares of Metlife by 30.6% during the 2nd quarter. Trust Co. of Vermont now owns 5,160 shares of the financial services provider’s stock worth $225,000 after acquiring an additional 1,209 shares during the last quarter. BTR Capital Management Inc. increased its holdings in shares of Metlife by 0.7% during the 3rd quarter. BTR Capital Management Inc. now owns 174,635 shares of the financial services provider’s stock worth $8,159,000 after acquiring an additional 1,261 shares during the last quarter. Finally, Independent Advisor Alliance increased its holdings in shares of Metlife by 4.7% during the 2nd quarter. Independent Advisor Alliance now owns 28,018 shares of the financial services provider’s stock worth $1,004,000 after acquiring an additional 1,265 shares during the last quarter. Institutional investors own 77.50% of the company’s stock.

NYSE MET traded up $0.06 on Tuesday, reaching $40.02. The stock had a trading volume of 696,149 shares, compared to its average volume of 6,663,963. The company has a debt-to-equity ratio of 0.29, a current ratio of 0.15 and a quick ratio of 0.15. Metlife Inc has a 1-year low of $39.31 and a 1-year high of $55.91. The firm has a market cap of $39.36 billion, a price-to-earnings ratio of 8.88, a P/E/G ratio of 0.60 and a beta of 1.23.



Metlife (NYSE:MET) last issued its quarterly earnings data on Wednesday, August 1st. The financial services provider reported $1.30 EPS for the quarter, beating analysts’ consensus estimates of $1.17 by $0.13. Metlife had a return on equity of 9.17% and a net margin of 6.12%. The firm had revenue of $21.22 billion for the quarter, compared to analyst estimates of $15.65 billion. During the same period in the prior year, the firm posted $1.04 EPS. The company’s revenue for the quarter was up 36.8% on a year-over-year basis. On average, equities analysts anticipate that Metlife Inc will post 5.21 earnings per share for the current fiscal year.

The company also recently disclosed a quarterly dividend, which will be paid on Thursday, December 13th. Shareholders of record on Tuesday, November 6th will be issued a $0.42 dividend. This represents a $1.68 dividend on an annualized basis and a yield of 4.20%. The ex-dividend date is Monday, November 5th. Metlife’s dividend payout ratio is 37.33%.

In other Metlife news, Chairman Steven A. Kandarian sold 42,805 shares of the company’s stock in a transaction on Monday, August 27th. The stock was sold at an average price of $47.03, for a total value of $2,013,119.15. Following the transaction, the chairman now directly owns 559,097 shares of the company’s stock, valued at approximately $26,294,331.91. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Also, Chairman Steven A. Kandarian sold 85,683 shares of the company’s stock in a transaction on Tuesday, August 21st. The shares were sold at an average price of $46.93, for a total value of $4,021,103.19. Following the completion of the transaction, the chairman now directly owns 585,005 shares in the company, valued at $27,454,284.65. The disclosure for this sale can be found here. Corporate insiders own 0.34% of the company’s stock.

A number of research analysts recently weighed in on the company. Zacks Investment Research lowered Metlife from a “buy” rating to a “hold” rating in a report on Friday, October 12th. UBS Group boosted their target price on Metlife from $48.00 to $49.00 and gave the stock a “neutral” rating in a report on Monday, October 8th. Wells Fargo & Co reissued a “buy” rating and set a $60.00 target price on shares of Metlife in a report on Thursday, September 27th. Credit Suisse Group decreased their target price on Metlife from $67.00 to $63.00 and set an “outperform” rating on the stock in a report on Friday, August 17th. Finally, Sandler O’Neill reissued a “hold” rating and set a $50.00 target price on shares of Metlife in a report on Thursday, August 2nd. One investment analyst has rated the stock with a sell rating, eight have issued a hold rating and seven have given a buy rating to the company. The stock currently has a consensus rating of “Hold” and an average price target of $55.00.

Metlife Profile

MetLife, Inc engages in the insurance, annuities, employee benefits, and asset management businesses. It operates through five segments: U.S.; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short- and long-term disability, individual disability, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and stable value products, including general and separate account guaranteed interest contracts, and private floating rate funding agreements.

See Also: How much money do you need to begin day trading?

Want to see what other hedge funds are holding MET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Metlife Inc (NYSE:MET).

Institutional Ownership by Quarter for Metlife (NYSE:MET)

Receive News & Ratings for Metlife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Metlife and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply